Comparative efficacy and safety of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and network meta-analysis

OBJECTIVE: To evaluate the comparative efficacy and safety of Janus kinase (JAK) inhibitors and biological disease-modifying antirheumatic drugs (bDMARDs) in patients with rheumatoid arthritis (RA) and an inadequate response to at least one disease-modifying antirheumatic drug (DMARD). METHODS: PubM...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Chenghua, Xue, Leixi, Wang, Qing, Lu, Wentian, Xu, Jiajun, Liu, Zhichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989112/
https://www.ncbi.nlm.nih.gov/pubmed/33815570
http://dx.doi.org/10.1177/1759720X21999564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989112/
https://www.ncbi.nlm.nih.gov/pubmed/33815570
http://dx.doi.org/10.1177/1759720X21999564

Ejemplares similares